Comparative Effectiveness and Coordinated Care in Hereditary Angioedema (HAE): What Does Managed Care Need to Know about Recently Approved Therapies?

A continuing medical education activity sponsored by NAMCP and AAMCN.

New Horizons in the Management of Hereditary Angioedema (HAE): What Managed Care Needs to Know About Novel Therapies in an Evolving Treatment Paradigm is a 3-part live webinar series that will provide attendees with the latest information in the management of Hereditary Angioedema

This is Part 3 of the series focusing on coordinated care in Hereditary Angioedema

This activity is an archive from the webinar held February 20, 2019

This activity is valid from March 1, 2019 to March 1, 2020

Instructions for CME/CNE: Complete the pre-test, listen to the audio and view the slides, complete the post test, complete the evaluation form and hit submit. You will be asked to enter your name and email address on the pre-test, evaluation and post-test. If you close your internet browser without completing the post test, you will have ONE more opportunity to complete. A score of 70% must be achieved on the post test to receive continuing education credits. If you do not pass the post test after two attempts, you will not be eligible to try again. Once you complete the evaluation form and score 70% or higher on your post test, you will automatically be given your certificate.

To print or save your certificate, you will need to click on the “download” button and either print or save.

 

Audience: This activity is intended for healthcare professionals practicing in managed care environments.

This presentation is supported by an educational grant from
CSL Behring

Description:
Hereditary angioedema (HAE) is a rare autosomal dominant condition characterized by recurrent attacks of edema at different locations of the body. This potentially life-threatening disease affects approximately 1 in 67,000 individuals. HAE is characterized by recurrent edema attacks and the cutaneous attacks can be disabling, with the skin, gastrointestinal tract, and upper airways are most commonly affected. Fortunately, novel therapies have recently become available that have shown improved efficacy and safety with improved administration methods. This webinar series will feature strategies to overcome challenges in the optimal long term treatment of HAE, updates on new therapies, and practical managed care approaches to provide cost-effective solutions to improve patient outcomes.

This webinar is part 3 of a 3-part live webinar series on novel therapies in HAE. This webinar will focus on managed care considerations and comparative effectiveness among novel therapies.

Upon completion of this activity, participants will be able to:

  • Identify key economic challenges surrounding management of patients with hereditary angioedema (HAE) and the need for more optimal medical intervention to reduce healthcare costs

  • Analyze safety and efficacy data of recently approved therapies for the prophylaxis of HAE

  • Apply methods to enable optimal cost management of novel therapies to be realized by multiple HAE stakeholders including managed care organizations
     

Faculty: Gary Owens, MD
President
Gary Owens Associates

Disclosure:

Dr. Owens has no real or perceived financial relationships to disclose. His presentation has been peer reviewed for any bias.
  Planning Committee:
Bill Williams, MD has no relevant financial relationships to disclose.
Jeremy Williams has no relevant financial relationships to disclose.
Will Williams has no relevant financial relationships to disclose.
Jacqueline Cole, RN, MS, CMCN has no relevant financial relationships to disclose.

NAMCP and/or the presenter has copyright or has received permissions for use of materials provided in this activity.

Accreditation & Designation
The National Association of Managed Care Physicians (NAMCP) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

NAMCP designates this enduring material for a maximum of 1 AMA PRA Category I creditsTM.

The American Association of Managed Care Nurses (AAMCN) is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation (ANCC).

Nurses who complete this activity and achieve a passing score will receive 1 hour in continuing
nursing credit.

This activity has been approved by the American Board of Managed Care Nursing for 1.0 contact hour toward CMCN recertification requirements.

This presentation is supported by an educational grant from
CSL Behring

NAMCP and/or this website does not provide medical advice, diagnosis or treatment. NAMCP does not endorse or imply endorsement of the content on any linked website. This website is to be used as an informational resource. With any health related concern, consult with your physician or healthcare professional.

Click Here To Continue